5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of the aurora kinase A inhibitor MLN8237 in patients with metastatic castrate resistant and neuroendocrine prostate cancer
    Meeting Abstract

    Beltran, H.; Rubin, M. A.; Mosquera, J. M.; Christos, P. J.; Calukovic, O.; Karpenko, I.; Pinski, J. K.; Danila, D. C.; Nanus, D. M.; Tagawa, S. T.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Preliminary safety, product parameters, and immune response assessments from a phase II randomized, open-label trial of DN24-02, an autologous cellular immunotherapy (ACI), in patients (pts) with surgically resected HER2+ urothelial cancer (UC) at high risk for recurrence
    Meeting Abstract

    Bajorin, D. F.; Sharma, P.; Lerner, S. P.; Sims, R. B.; Sanders, A.; DeVries, T.; Sheikh, N. A.; Gomella, L. G.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Association of bone scan index (BSI) with prognostic biomarkers and survival in men with metastatic castration-resistant prostate cancer (mCRPC) enrolled in a prospective randomized controlled trial of tasquinimod
    Meeting Abstract

    Armstrong, A. J.; Kaboteh, R.; Carducci, M. A.; Damber, J. E.; Stadler, W. M.; Mats, H.; Edenbrandt, L.; Forsberg, G.; Nordle, O.; Pili, R.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • ERG rearrangements and association with clinical outcome in patients (pts) receiving abiraterone acetate (AA): Results from the COU-AA-302 study in chemotherapy (chemo)-naïve metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Attard, G.; De Bono, J. S.; Li, W.; Molina, A.; Griffin, T. W.; Kheoh, T. S.; Ricci, D. S.; Zelinsky, K.; Rathkopf, D. E.; Scher, H. I.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Evaluating 18F-16B-fluoro-5α-dihydrotestosterone (FDHT) and FDG-PET as a measure of disease progression in metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Autio, K. A.; Fox, J. J.; Schneider, C. W.; Schöder, H.; Humm, J.; Rathkopf, D. E.; Slovin, S. F.; Danila, D. C.; Haupt, E. C.; Larson, S. M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II randomized study of dalantercept in combination with axitinib compared to axitinib alone as second-line treatment in patients with metastatic renal cell carcinoma
    Meeting Abstract

    Atkins, M. B.; Bhatt, R. S.; Voss, M. H.; Rini, B. I.; Jonasch, E.; Plimack, E. R.; Alter, R.; Barger, R.; Wilson, D.; McClure, T.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Prostate-specific mRNA detection in whole blood as an analytically validated prognostic biomarker for patients with castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Anand, A.; Danila, D. C.; Heller, G.; Herkal, A.; Patel, C.; Khanin, R.; Schultz, N.; Lilja, H.; Fleisher, M.; Scher, H. I.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase I study of nivolumab (anti-PD-1; BMS-936558; ONO-4538) in combination with sunitinib, pazopanib, or ipilimumab in patients (pts) with metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Amin, A.; Ernstoff, M. S.; Infante, J. R.; Heng, D. Y. C.; Rini, B. I.; Plimack, E. R.; McDermott, D. F.; Kollmannsberger, C. K.; Reaume, M. N.; Spratlin, J. L.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Reduced proficiency in homologous recombination underlies the high sensitivity of embryonal carcinoma testicular germ cell tumors to cisplatin and poly (ADP-ribose) polymerase inhibition
    Meeting Abstract

    Cavallo, F.; Graziani, G.; Antinozzi, C.; Feldman, D. R.; Houldsworth, J.; Bosl, G. J.; Chaganti, R. S. K.; Moynahan, M. E.; Jasin, M.; Barchi, M.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Molecular biomarkers for patients with castration-resistant prostate cancer: Validating assays predictive of tumor response
    Book Section

    Danila, D. C.; Scher, H. I.
    In Goodsaid, F.; Mattes, W. B. (Eds.) The Path from Biomarker Discovery to Regulatory Qualification (2013)

    Fulltext@MSK | Save